Financhill
Sell
39

IMVT Quote, Financials, Valuation and Earnings

Last price:
$25.63
Seasonality move :
-11.86%
Day range:
$25.62 - $26.95
52-week range:
$12.72 - $27.92
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.35x
Volume:
1.4M
Avg. volume:
1.6M
1-year change:
34.13%
Market cap:
$5.3B
Revenue:
--
EPS (TTM):
-$2.68

Earnings Data

Next earnings date for IMVT
May 28
2026
Most recent earnings per share
-$0.61
Beat by $0.08
(Feb 6/2026)
Consensus Estimate
-$0.69
(Feb 6/2026)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

IMVT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/28/2026 Q1 -- -- -- -$0.58 --
02/06/2026 Q4 -- -- -$0.61 -$0.69 $0.08
11/10/2025 Q3 -- -- -$0.73 -$0.73 -$0.00
08/11/2025 Q2 -- -- -$0.71 -$0.67 -$0.03
05/28/2025 Q1 -- -- -$0.64 -$0.72 $0.08
02/06/2025 Q4 -- -- -$0.76 -$0.75 -$0.00
11/07/2024 Q3 -- -- -$0.75 -$0.61 -$0.14
08/06/2024 Q2 -- -- -$0.60 -$0.52 -$0.08
05/29/2024 Q1 -- -- -$0.52 -$0.43 -$0.09
02/12/2024 Q4 -- -- -$0.36 -$0.42 $0.06
11/09/2023 Q3 -- -- -$0.45 -- --
08/10/2023 Q2 -- -- -$0.57 -- --
05/22/2023 Q1 -- -- -$0.46 -- --
02/03/2023 Q4 -- -- -$0.49 -- --
11/04/2022 Q3 -- -- -$0.41 -- --
08/05/2022 Q2 -- -- -$0.35 -- --
06/08/2022 Q1 -- -- -$0.41 -- --
02/04/2022 Q4 -- -- -$0.36 -- --
11/05/2021 Q3 -- -- -$0.35 -- --
08/06/2021 Q2 -- -- -$0.31 -- --
06/01/2021 Q1 -- -- -$0.29 -- --
02/16/2021 Q4 -- -- -$0.32 -- --
11/12/2020 Q3 -- -- -$0.25 -- --
08/12/2020 Q2 -- -- -$0.38 -- --
06/29/2020 Q1 -- -- -$0.38 -- --
02/14/2020 Q4 -- -- -$0.28 -- --
09/30/2019 Q3 -- -- $0.01 -- --
08/12/2019 Q2 -- -- $0.01 -- --
06/12/2019 Q1 -- -- -$0.00 -- --

Immunovant, Inc. Earnings Questions

  • How Much did Immunovant, Inc. Generate in Revenue Last Quarter?

    Immunovant, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Immunovant, Inc. Beat Earnings Last Quarter?

    Immunovant, Inc. announced earnings per share of -$0.61 which represents a beat of analyst forecast a -$0.69 per share.

  • Is Immunovant, Inc. Profitable?

    Immunovant, Inc. reported -$101K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Immunovant, Inc. EPS Next Year?

    Immunovant, Inc.'s earnings are forecast to decrease from -$2.73 per share to -$2.87 per share next year representing a decrease of -5.04%.

  • When is Immunovant, Inc.'s Earnings Date?

    Immunovant, Inc.'s next earnings date is May 28, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
58
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Sell
40
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
91
TDC alert for Feb 12

Teradata Corp. [TDC] is down 11.64% over the past day.

Buy
67
DIOD alert for Feb 12

Diodes, Inc. [DIOD] is down 7.63% over the past day.

Buy
77
VRT alert for Feb 12

Vertiv Holdings Co. [VRT] is down 4.79% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock